Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Int J Mol Sci ; 24(11)2023 Jun 02.
Article in English | MEDLINE | ID: mdl-37298648

ABSTRACT

Two forms were found in the NMR spectra of N6-substituted 2-chloroadenosines. The proportion of the mini-form was 11-32% of the main form. It was characterized by a separate set of signals in COSY, 15N-HMBC and other NMR spectra. We assumed that the mini-form arises due to the formation of an intramolecular hydrogen bond between the N7 atom of purine and the N6-CH proton of the substituent. The 1H,15N-HMBC spectrum confirmed the presence of a hydrogen bond in the mini-form of the nucleoside and its absence in the main form. Compounds incapable of forming such a hydrogen bond were synthesized. In these compounds, either the N7 atom of the purine or the N6-CH proton of the substituent was absent. The mini-form was not found in the NMR spectra of these nucleosides, confirming the importance of the intramolecular hydrogen bond in its formation.


Subject(s)
Protons , Hydrogen Bonding , 2-Chloroadenosine , Magnetic Resonance Spectroscopy
2.
Int J Mol Sci ; 24(7)2023 Mar 25.
Article in English | MEDLINE | ID: mdl-37047197

ABSTRACT

A number of purine arabinosides containing chiral amino acid amides at the C6 position of the purine were synthesized using a transglycosylation reaction with recombinant E. coli nucleoside phosphorylases. Arsenolysis of 2-chloropurine ribosides with chiral amino acid amides at C6 was used for the enzymatic synthesis, and the reaction equilibrium shifted towards the synthesis of arabinonucleosides. The synthesized nucleosides were shown to be resistant to the action of E. coli adenosine deaminase. The antiproliferative activity of the synthesized nucleosides was studied on human acute myeloid leukemia cell line U937. Among all the compounds, the serine derivative exhibited an activity level (IC50 = 16 µM) close to that of Nelarabine (IC50 = 3 µM) and was evaluated as active.


Subject(s)
Escherichia coli , Purine Nucleosides , Humans , Purine Nucleosides/pharmacology , Escherichia coli/metabolism , Amino Acids , Nucleosides/chemistry , Arabinonucleosides
3.
Bioorg Chem ; 126: 105878, 2022 09.
Article in English | MEDLINE | ID: mdl-35660725

ABSTRACT

A series of purine ribonucleosides bearing chiral amino acid amides at the C6 position of 2-chloropurine was synthesized. Molecular docking of the synthesized analogs of 2-chloroadenosine by their affinity for A1 adenosine receptors (A1ARs) was conducted. The investigation of A1AR stimulating activity of synthesized nucleosides was carried out in a model of an isolated mouse atrium. We have shown that derivatives with tyrosine, valine, and serine residues exhibit the properties of A1AR partial agonists. Animal experiments in the open field test have shown that these compounds have different profiles of psychoactive action. These nucleosides have an ophthalmic hypotensive effect and reduce intraocular pressure in a manner slightly inferior to that of timolol and brimonidine. The synthesized nucleosides can be the basis for further design and synthesis of new A1AR agonists.


Subject(s)
Amino Acids , Purinergic P1 Receptor Agonists , Amides/pharmacology , Amino Acids/pharmacology , Animals , Mice , Molecular Docking Simulation , Nucleosides , Receptor, Adenosine A1/metabolism
4.
Chem Biol Drug Des ; 93(4): 605-616, 2019 04.
Article in English | MEDLINE | ID: mdl-30561886

ABSTRACT

A series of ribo- and deoxyribonucleosides bearing 2-aminopurine as a nucleobase with 7,8-difluoro- 3,4-dihydro-3-methyl-2H-[1,4]benzoxazine (conjugated directly or through an aminohexanoyl spacer) was synthesized using an enzymatic transglycosylation reaction. Nucleosides 3-6 were resistant to deamination under action of adenosine deaminase (ADA) Escherichia coli and ADA from calf intestine. The antiviral activity of the modified nucleosides was evaluated against herpes simplex virus type 1 (HSV-1, strain L2). It has been shown that at sub-toxic concentrations, nucleoside (S)-4-[2-amino-9-(ß-D-ribofuranosyl)-purin-6-yl]-7,8-difluoro-3,4-dihydro-3-methyl-2H-[1,4]benzoxazine exhibit significant antiviral activity (SI > 32) on the model of HSV-1 in vitro, including an acyclovir-resistant virus strain (HSV-1, strain L2/R).


Subject(s)
Adenosine Deaminase/metabolism , Antiviral Agents/metabolism , Benzoxazines/chemistry , Purine Nucleosides/biosynthesis , Animals , Antiviral Agents/chemistry , Antiviral Agents/pharmacology , Cell Survival/drug effects , Chlorocebus aethiops , Drug Resistance, Viral/drug effects , Escherichia coli/enzymology , Escherichia coli Proteins/metabolism , Herpesvirus 1, Human/drug effects , Humans , Purine Nucleosides/chemistry , Purine Nucleosides/pharmacology , Stereoisomerism , Vero Cells
5.
Beilstein J Org Chem ; 14: 3098-3105, 2018.
Article in English | MEDLINE | ID: mdl-30643587

ABSTRACT

Phosphoribosyltransferases are the tools that allow the synthesis of nucleotide analogues using multi-enzymatic cascades. The recombinant adenine phosphoribosyltransferase (TthAPRT) and hypoxanthine phosphoribosyltransferase (TthHPRT) from Thermus thermophilus HB27 were expressed in E.coli strains and purified by chromatographic methods with yields of 10-13 mg per liter of culture. The activity dependence of TthAPRT and TthHPRT on different factors was investigated along with the substrate specificity towards different heterocyclic bases. The kinetic parameters for TthHPRT with natural substrates were determined. Two nucleotides were synthesized: 9-(ß-D-ribofuranosyl)-2-chloroadenine 5'-monophosphate (2-Сl-AMP) using TthAPRT and 1-(ß-D-ribofuranosyl)pyrazolo[3,4-d]pyrimidine-4-one 5'-monophosphate (Allop-MP) using TthНPRT.

6.
Bioorg Med Chem Lett ; 27(11): 2484-2487, 2017 06 01.
Article in English | MEDLINE | ID: mdl-28408228

ABSTRACT

Using the enzymatic transglycosylation reaction ß-d-ribo- and 2'-deoxyribofuranosides of 2-amino-5,6-difluorobenzimidazole nucleosides have been synthesized. 2-Amino-5,6-difluoro-benzimidazole riboside proved to exhibit a selective antiviral activity (selectivity index >32) against a wild strain of the herpes simplex virus type 1, as well as towards virus strains that are resistant to acyclovir, cidofovir, and foscarnet. We believe that this compound might be used for treatment of herpes infections in those cases, when acyclovir is not efficient.


Subject(s)
Antiviral Agents/chemical synthesis , Benzimidazoles/chemistry , Nucleosides/chemistry , Acyclovir/pharmacology , Antiviral Agents/pharmacology , Cidofovir , Cytosine/analogs & derivatives , Cytosine/pharmacology , Drug Resistance, Viral/drug effects , Foscarnet/pharmacology , Herpesvirus 1, Human/drug effects , Humans , Nucleosides/pharmacology , Organophosphonates/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...